SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Hematocrit Stabilized in Polycythemia Vera Under Novel Hepcidin Mimetic Treatment.

2.

Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.

3.

Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.

4.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

5.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot